3D Neuroscience Market size is poised to reach USD 52 Billion by the end of 2036, growing at a CAGR of 4% during the forecast period, i.e. 2024-2036. In the year 2023, the industry size of 3D neuroscience was USD 33 Billion. In neuroscience research and clinical applications, the demand for advanced imaging and visualization technologies is increasing. In 2021, the global industry size of advanced visual display technologies is expected to reach USD 2.52 billion, which will be increased to USD 5.08 billion by 2030. Factors such as an increasing incidence of neurological disorders, the need to better understand brain function and continuing technological developments in medical technology are driving this market. In particular, academic and research institutions, neuroscience laboratories, and hospitals are driving the adoption of 3D tools and techniques. These institutions are investing in advanced imaging systems, software and analysis tools with a view to enhancing their research capabilities and improving the health outcomes of patients.
In addition, advanced imaging systems with higher resolution, faster scanning and improved data analysis and visualisation capabilities are being developed and introduced by key players in the 3D neuroscience market. The integration of a wide range of imaging modalities, e.g. MRI, CT or Microscopy, is also becoming increasingly important for the purpose of an overall view of brain function and functioning.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~ 4% |
|
Base Year Market Size (2023) |
~ USD 33 Billion |
|
Forecast Year Market Size (2036) |
~ USD 52 Billion |
|
Regional Scope |
|
Technology (Brain imaging, Neuro-Microscopy, Electrophysiology, Neuroproteomic)
Brain Imaging Segment in the 3D neuroscience market is estimated to hold 42% of the revenue share during the forecast period. The increased usage of brain imaging devices, including MRI, EEG, and CT scans, in hospitals, diagnostic centers, and ambulatory surgical centers has led to the diagnosis of neurological diseases. According to a report by NHS England and NHS Improvement in 2022, approximately 67,215 individuals were referred for brain MRI scans in March 2022 to diagnose cancer. Therefore, the rising adoption of brain imaging techniques has increased demand for imaging devices in the upcoming years.
End User (Hospital, Diagnostic Laboratories, Research and Academic Institutes)
Diagnostic Laboratories segment in the 3D neuroscience market is established to attain majority revenue share. The main drivers of the industry's expansion are the growing usage of neurological devices in diagnostic labs and growing public awareness of the advantages of early disease diagnosis. According to the Parkinson's Foundation, around 90,000 individuals receive a Parkinson's disease diagnosis each year. Diagnostic facilities frequently employ neurology instruments such as electroencephalograms (EEG), electromyograms (EMG), CT scans, MRIs, and others for diagnosis. Thus, it is anticipated that the development of robust, safe, and efficient neurological equipment will propel the market’s expansion.
Our in-depth analysis of the global market includes the following segments:
|
Technology |
|
|
End User |
|
|
Component |
|
North American Market Forecast
North American 3D neuroscience market is estimated to hold the largest revenue share over the forecast period, accounting for 36% of the global market. The growth of the neuroscience industry in North America is expected to continue due to the increasing incidence of brain-related diseases. It was observed by Research Nester analysts, in 2019, Neurological conditions accounted 533,172 deaths, 213,129 (40%) in men, and 320,043 (60%) in women .To support this growth, several institutions, universities, and organizations are dedicated to promoting research & development in this field. The United States government is concerned about the high number of deaths related to these diseases and has increased funding accordingly. Major market players are also introducing technological innovations to further boost growth, and the approval of new products will be an important factor in expanding the 3D neuroscience market . Overall, the industry is projected to grow over the forecast period.
APAC Market Statistics
The 3D neuroscience market in Asia Pacific is anticipated to grow significantly during the projected period. As the population of Asia and the Pacific region grows, more information is becoming available about numerous neurological disorders. China, Japan, and India are consequently increasing their health care spending, which has an impact on trade. It is also anticipated that there would be a greater demand for precise diagnosis and treatment of various forms of brain disease as a result of this rise in their prevalence. As a result, a growth in the 3D neuroscience market is anticipated.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?